<DOC>
	<DOCNO>NCT00818129</DOCNO>
	<brief_summary>The primary objective study investigate safety tolerability single multiple oral dos AZD7295 healthy male Japanese subject . This do comparing effect AZD7295 placebo . The study aslo investigate absorption , distribution disappearance AZD7295 body .</brief_summary>
	<brief_title>Study Investigate Safety , Tolerability PK Following Single Multiple Ascending Doses AZD7295 Japanese</brief_title>
	<detailed_description />
	<criteria>Provision sign , write date informed consent Healthy male Japanese volunteer age 2055 year BMI 18 27 kg/m2 Have negative screen HIV , hepatitis B C viruses syphilis Use prescribe medication within 2 week prior dose study medication Participation another study include drug treatment within 16 week start present study . History presence gastrointestinal , hepatic renal disease condition know interfere absorption , distribution , metabolism excretion drug . History severe food drug allergy/hypersensitivity ongoing allergy/hypersensitivity , judge relevant investigator .</criteria>
	<gender>Male</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>July 2009</verification_date>
	<keyword>Phase I</keyword>
	<keyword>Japan</keyword>
	<keyword>Japanese</keyword>
	<keyword>oral solution</keyword>
</DOC>